Tag: Radiation Oncology

Researchers use AI tools to uncover connections between radiotherapy for lung cancer and heart complications

AI SummaryResearchers have utilized artificial intelligence tools to investigate the relationship between radiotherapy for lung cancer and heart complications, specifically focusing on the risk of cardiac arrhythmias. By studying how different parts of the heart are affected by varying levels of radiation, they aim to improve treatment plans and minimize potential side effects. This research… Continue reading Researchers use AI tools to uncover connections between radiotherapy for lung cancer and heart complications

[News] Peru advances towards universal health care for patients with cancer

On July 29, 2024, the International Atomic Energy Agency (IAEA) issued a statement praising Peru’s advances towards delivering universal health care for patients with cancer. The IAEA stated that nuclear medicine and radiotherapy services in Peru were being decentralised from Lima, the capital city, and that the country had extended coverage of the human papillomavirus… Continue reading [News] Peru advances towards universal health care for patients with cancer

[Articles] Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial

AI SummaryThe article discusses a phase 2 trial comparing adaptive radiotherapy (up to 74 Gy) with standard radiotherapy (66 Gy) for stage III non-small-cell lung cancer patients based on interim [18F]FDG-PET results. It found that a thoracic radiotherapy boost, guided by [18F]FDG-PET, improved local control rates with no increase in adverse events, which may warrant… Continue reading [Articles] Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial

Hypofractionated Postprostatectomy Radiotherapy

AI SummaryThe article discusses the results of a phase 3 randomized clinical trial comparing hypofractionated postprostatectomy radiotherapy to conventional fractionation. It found that hypofractionation was noninferior in terms of patient-reported late adverse effects at 2 years. This suggests that hypofractionated postprostatectomy radiotherapy may be a viable alternative to conventional fractionation with potentially similar outcomes.To the… Continue reading Hypofractionated Postprostatectomy Radiotherapy

Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation

AI SummaryThis article discusses a randomized clinical trial comparing the outcomes of hypofractionation versus conventional fractionation postmastectomy radiation therapy regimens in patients undergoing implant-based breast reconstruction.This randomized clinical trial compares the outcomes of hypofractionation vs conventional fractionation postmastectomy radiation therapy regimens in patients undergoing implant-based breast reconstruction.

Relapse Patterns in Early-Stage Endometrial Cancer Based on Molecular Classification—Reply

In Reply We thank Bogani and Raspagliesi for their interest in our study, which aimed to assess the differences in risk-adaptive adjuvant radiotherapy for International Federation of Gynecology and Obstetrics (FIGO) 2009 stage I endometrioid endometrial cancer (EC) in The Cancer Genome Atlas (TCGA), guided by traditional clinicopathologic features vs molecular classification (MC). The correspondents… Continue reading Relapse Patterns in Early-Stage Endometrial Cancer Based on Molecular Classification—Reply

Relapse Patterns in Early-Stage Endometrial Cancer Based on Molecular Classification

AI SummaryThe article discusses the use of molecular classification in early-stage endometrial cancer to determine relapse patterns and the potential overutilization or underutilization of radiotherapy. It points out the importance of validating the value of molecular classification with prospective data and emphasizes the need to consider factors such as myometrial invasion and chemotherapy administration when… Continue reading Relapse Patterns in Early-Stage Endometrial Cancer Based on Molecular Classification

[Articles] Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial

AI SummaryThis article discusses the 30-year update of a randomized controlled trial on postoperative radiotherapy in women with early operable breast cancer. The study suggests that patients with biology predicting late relapse may not benefit significantly from adjuvant radiotherapy after breast-conserving surgery.Our findings suggest that patients whose biology predicts a late relapse a decade or… Continue reading [Articles] Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial

Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence

AI SummaryThis study examined changes in Merkel cell oncoprotein antibodies in patients with Merkel cell carcinoma (MCC) who underwent radiation therapy (RT) and the association with recurrence. The research found that positive baseline levels of these antibodies were linked to younger age at MCC diagnosis and non-head and neck tumor location, potentially related to viral… Continue reading Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence